Zymeworks (ZYME) Exchange Rate Effect (2021 - 2026)
Zymeworks' (ZYME) quarterly Exchange Rate Effect came in at $98000.0 in Q1 2026, up 880.0% year-on-year from $10000.0 in Q1 2025, and up 322.73% quarter-over-quarter from -$44000.0 in Q4 2025.
Zymeworks (ZYME) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Exchange Rate Effect across 6 years of filings, most recently posting $98000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $98000.0, up 880.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $43000.0 (down 75.71% YoY), and the FY2025 annual result was -$45000.0, down 115.73% from the prior year.
- Exchange Rate Effect came in at $98000.0 for Q1 2026 at Zymeworks, up from -$44000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $346000.0 in Q1 2023 to a low of -$123000.0 in Q1 2022.
- The 5-year median for Exchange Rate Effect is $23000.0 (2023), against an average of $52705.9.
- Across the five-year window, Exchange Rate Effect jumped 3866.67% in 2024 and plunged 241.94% in 2025, its largest moves.
- Zymeworks' Exchange Rate Effect stood at -$88000.0 in 2022, then soared by 96.59% to -$3000.0 in 2023, then surged by 3866.67% to $113000.0 in 2024, then tumbled by 138.94% to -$44000.0 in 2025, then soared by 322.73% to $98000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $98000.0 (Q1 2026), -$44000.0 (Q4 2025), and $77000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |